Skip to main content
. 2010 Apr 26;4:331–341. doi: 10.2147/opth.s9163

Table 1.

Minimum inhibitory concentrations (MIC90) for besifloxacin, moxifloxacin, and gatifloxacin against selected Staphylococcus isolates

Number of isolates Besifloxacin (μg/mL) MIC90 Moxifloxacin (μg/mL) MIC90 Gatifloxacin (μg/mL) MIC90
S. aureus
 MSSA-CSa 144 0.06 0.12 0.25
 MRSA-CRb 81 4 32 64
S. epidermidis
 MSSE-CSc 50 0.06 0.12 0.25
 MRSE-CRd 29 4 64 128
a

MIC90 values were obtained from susceptibility testing of 144 methicillin-sensitive, ciprofloxacin-sensitive S. aureus isolates.7

b

MIC90 values were obtained from susceptibility testing of 81 methicillin-resistant, ciprofloxacin-resistant S. aureus isolates.24

c

MIC90 values were obtained from susceptibility testing of 50 methicillin-sensitive, ciprofloxacin-sensitive S. epidermidis isolates.7

d

MIC90 values were obtained from susceptibility testing of 29 methicillin-resistant, ciprofloxacin-resistant S. epidermidis isolates.24

Abbreviations: MIC90, minimum inhibitory concentration to inhibit 90% of isolates; MSSA-CS, methicillin- and ciprofloxacin-sensitive S. aureus; MRSA-CR, methicillin- and ciprofloxacin-resistant S. aureus; MSSE-CS, methicillin- and ciprofloxacin-sensitive S. epidermidis; MRSE-CR, methicillin- and ciprofloxacin-resistant S. epidermidis.